TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Aster DM Quality Care Ltd.

ASTERDM on NSE · 19 Nov 2026

NIFTY 500

739.30 ▲ +1.14 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

Guidance tracker

What ASTERDM guided, and what came next

FiledWhat the filing saysNext results: profit YoYRevenueMove on the day
13 Nov 2026Aster DM Quality Care filed the transcript of its earnings conference call held on 6 November 2026 for the quarter and half-year ended 30 September 2026. Management (Varun Khanna, MD & Group CEO) said Q2 FY27 was the first full quarter after the merger, with record revenue of INR 2,829 crore (up 19% year-on-year),... NSE copy No results filed since
14 Oct 2026Aster DM Quality Care Limited filed the transcript of its 18th Annual General Meeting, held through video conferencing on 28 September 2026. Management said the merger of Aster DM Healthcare Limited and Quality Care India Limited became effective on 1 July 2026, and the combined network recorded proforma revenue of... NSE copy +138.2 %+136.3 %+2.9 %
12 Aug 2026Aster DM Quality Care filed the transcript of its Q1 FY27 earnings conference call held on 5 August 2026 for the quarter ended 30 June 2026, the first call after the Aster DM Healthcare and Quality Care merger (effective 1 July 2026). Management said combined proforma revenue from operations rose 20% YoY to INR... NSE copy +138.2 %+136.3 %+2.9 %
08 May 2026Aster DM Healthcare filed the transcript of its Q4 and FY26 earnings conference call held May 1, 2026, on the audited results for the quarter and year ended March 31, 2026. Management said combined proforma (Aster plus Quality Care) Q4 revenue grew 18% year-on-year to INR 2,361 crores and Operating EBITDA rose 25%... NSE copy -81.2 %+21.6 %+0.3 %
09 Feb 2026Aster DM Healthcare filed the transcript of its Q3 FY26 earnings conference call held February 2, 2026, for the quarter and nine months ended December 31, 2025. Management said Aster revenue from operations was INR 1,186 crore, up 13% year-on-year, with operating EBITDA of INR 224 crore (up 11%, margin 18.9%);... NSE copy --+6.2 %
30 Jan 2026Aster DM Healthcare filed its investor presentation for the quarter and nine months ended December 31, 2025 (Q3FY26). Combined proforma entity (Aster + QCIL) revenue from operations rose 15% YoY to INR 2,366 crores; total patient volume grew 9% YoY to 1.97 Mn. Merged entity operating EBITDA rose 22% YoY to INR 503... NSE copy --+6.2 %
14 Nov 2025Aster DM Healthcare filed the transcript of its Q2 FY26 earnings conference call (held November 7, 2025) for the quarter and half year ended September 30, 2025. Management reported Q2 FY26 revenue up 10% YoY to INR 1,197 Crore and Operating EBITDA of INR 263 Crore at a 22.0% margin; Normalised PAT (post NCI) of INR... NSE copy -7.6 %+12.9 %+3.3 %
10 Sep 2025Aster DM Healthcare filed the transcript of its 17th Annual General Meeting, held on September 4, 2025 by video conferencing. Chairperson Alisha Moopen, chairing in the absence of Chairman Dr. Azad Moopen, said the merger with Quality Care India Limited (QCIL, backed by Blackstone) is the largest M&A in the... NSE copy +13.6 %+10.2 %+0.8 %
28 May 2025Aster DM Healthcare filed the transcript of its Q4 and FY25 earnings call held May 21, 2025, under Regulation 30 of the SEBI Listing Regulations. Management reported FY25 revenue of INR 4,138 crore (up 12% from INR 3,699 crore) and operating EBITDA of INR 806 crore (up 30%), with operating EBITDA margin at 19.5%... NSE copy +15.6 %+7.6 %+2.0 %
20 May 2025Aster DM Healthcare filed its investor presentation for the quarter and year ended March 31, 2025. Q4 FY25 revenue was INR 1,000 cr (Q4 FY24: INR 978 cr), operating EBITDA INR 193 cr (Q4 FY24: INR 167 cr) with a 19.3% margin, and normalised PAT (post-NCI) INR 106 cr (Q4 FY24: INR 87 cr). FY25 revenue was INR 4,138... NSE copy +15.6 %+7.6 %+2.0 %
10 Feb 2025Aster DM Healthcare filed the transcript of its Q3 and 9M FY25 earnings call held on February 3, 2025, along with a covering letter dated February 10, 2025. Management (Alisha Moopen) said India revenue for 9M FY25 rose 15% to INR 3,138 crore, operating EBITDA rose 35% to INR 613 crore, and EBITDA margin expanded... NSE copy +15.6 %+7.6 %+2.0 %
31 Jan 2025Investor presentation for the quarter and nine months ended December 31, 2024 (Q3 and 9M FY25) filed by Aster DM Healthcare Limited. 9M FY25 revenue INR 3,138 cr (9M FY24: INR 2,721 cr), up 15%; Operating EBITDA INR 613 cr (9M FY24: INR 453 cr), up 35%; Operating EBITDA margin 19.5% (9M FY24: 16.6%). 9M FY25... NSE copy +15.6 %+7.6 %+2.0 %
06 Dec 2024Aster DM Healthcare filed the transcript of its November 29, 2024 investor conference call on the proposed merger with Quality Care India Limited (QCIL), a Blackstone-backed entity. Management said the deal values QCIL at 25.2x and Aster at 36.6x FY24 adjusted post-IND AS EV/EBITDA; Aster promoters and Blackstone... NSE copy -68.3 %-71.7 %-3.3 %

Filings tagged as guidance, newest first (13 in all), with the company's next results after each: profit and revenue against the same quarter a year before, and the share's move on the results day. Whether the guidance was met is for the reader to judge from both; the site does not score it. The summaries are written by an AI model from the filing and can be wrong - the filing is the source.

Governance

Management, auditors, ratings and legal matters

FiledKindWhat the filing says
06 Nov 2026Legal or regulatoryAster DM Quality Care filed the outcome of its 6 November 2026 board meeting with BSE and NSE. The board approved converting a loan of INR 102.46 Cr extended to its wholly owned subsidiary Sri Sainatha Multispeciality Hospitals Private Limited into 10,24,62,779 equity shares of face value INR 10 each, as part of... NSE copy
16 Sep 2026Credit ratingAster DM Quality Care Limited filed intimation under Regulation 30 of the Listing Regulations on a credit rating revision of KIMS Healthcare Management Limited, its material subsidiary, by ICRA Limited. Long-term fund-based cash credit (Rs. 19.00 crore) and term loan (Rs. 75.00 crore) upgraded from [ICRA]AA- to... NSE copy
29 Aug 2026Legal or regulatoryAster DM Quality Care Limited filed that the boards of KIMSHEALTH Executive Leisure Private Limited (KEL) and Spiceretreat Hospitality Services Private Limited (SHSPL), its step-down subsidiaries, approved a Scheme of Amalgamation of KEL with SHSPL on 29 August 2026, subject to statutory and regulatory approvals.... NSE copy
05 Aug 2026Legal or regulatoryAster DM Quality Care Limited's board on 5 August 2026 approved a postal ballot notice, convened its 18th Annual General Meeting for 28 September 2026 at 11:30 A.M. IST via video conferencing, and approved termination of the operations and management agreement for Aster G. Madegowda Hospital, Maddur, effective on... NSE copy
30 Jul 2026Credit ratingCRISIL Ratings Limited has assigned long-term bank facilities a rating of Crisil AA+/Stable and short-term bank facilities a rating of Crisil A1+, both marked as assigned. Total rated amount is ₹860.50 crore. The rated facilities were novated from Quality Care India Ltd (QCIL) following its merger with the Company,... NSE copy
10 Jul 2026Credit ratingAster DM Quality Care Limited filed intimation under Regulation 30 of a revised credit rating from ICRA Limited dated July 10, 2026. Long-term fund-based term loan rated amount raised from ₹382.00 crore to ₹1,607.00 crore; ICRA upgraded it from [ICRA]A+ to [ICRA]AA (Stable), removed it from Rating Watch with... NSE copy
01 Jul 2026Legal or regulatory, Management changeBoard of Aster DM Healthcare Limited (ASTERDM) met on 1 July 2026 and approved several changes, subject to shareholder approval where stated, with effect from 1 July 2026 unless noted. Appointed Mr. Varun Khanna as Additional Director and Managing Director & Group CEO for five years; appointed Mr. Neeraj Jain, Mr.... NSE copy
25 Jun 2026Legal or regulatoryBoard of Aster DM Healthcare met on 25 June 2026 and took on record the NCLT Hyderabad Bench order dated 19 June 2026 approving the Scheme of Amalgamation of Quality Care India Limited (transferor) into Aster DM Healthcare Limited (transferee). The Board fixed 9 July 2026 as the Record Date for determining... NSE copy
08 May 2026Legal or regulatoryAster DM Healthcare filed the transcript of its Q4 and FY26 earnings conference call held May 1, 2026, on the audited results for the quarter and year ended March 31, 2026. Management said combined proforma (Aster plus Quality Care) Q4 revenue grew 18% year-on-year to INR 2,361 crores and Operating EBITDA rose 25%... NSE copy
10 Mar 2026Management changeBoard of Aster DM Healthcare approved the appointment of Dr. Azad Moopen (DIN: 00159403) as Executive Director, redesignated from Managing Director, for a term from April 15, 2026 to May 28, 2028, subject to shareholder approval by postal ballot. Dr. Azad Moopen will continue to act as Chairman of the Company. Dr.... NSE copy
09 Feb 2026Management changeAster DM Healthcare filed the transcript of its Q3 FY26 earnings conference call held February 2, 2026, for the quarter and nine months ended December 31, 2025. Management said Aster revenue from operations was INR 1,186 crore, up 13% year-on-year, with operating EBITDA of INR 224 crore (up 11%, margin 18.9%);... NSE copy
30 Jan 2026Legal or regulatoryAster DM Healthcare filed the outcome of its board meeting held on January 30, 2026, including unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, with an unmodified limited review report from Deloitte Haskins & Sells. The board approved the Aster DM... NSE copy
30 Jan 2026Legal or regulatoryAster DM Healthcare filed the outcome of its Board meeting held on January 30, 2026, including unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, with an unmodified limited review opinion from Deloitte Haskins & Sells. The Board approved the Aster DM... NSE copy
06 Nov 2025Legal or regulatory, Management changeBoard of Aster DM Healthcare approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025; the statutory auditor (Deloitte Haskins & Sells) issued an unmodified review opinion. Non-Executive Director Mr. Anoop Moopen resigned with effect from close of... NSE copy
06 Nov 2025Legal or regulatory, Management changeBoard of Aster DM Healthcare approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025; statutory auditor Deloitte Haskins & Sells issued an unmodified review opinion. Non-Executive Director Mr. Anoop Moopen resigned with effect from close of business on... NSE copy
06 Oct 2025Legal or regulatoryAster DM Healthcare received no-objection letters with 'no adverse observations' from BSE and NSE on October 06, 2025 for the proposed scheme of merger of Quality Care India Limited (transferor) into Aster DM Healthcare Limited (transferee) under sections 230-232 of the Companies Act, 2013. The scheme remains... NSE copy
03 Oct 2025Credit ratingAster DM Healthcare Limited filed intimation of a revised credit rating by ICRA Limited under Regulation 30 of the SEBI Listing Regulations, dated October 03, 2025. ICRA upgraded the long-term fund-based term loan (Rs. 382 crore) to [ICRA]A+ from [ICRA]A and kept it on Rating Watch with Positive Implications. ICRA... NSE copy
10 Sep 2025Legal or regulatory, Management changeAster DM Healthcare filed the transcript of its 17th Annual General Meeting, held on September 4, 2025 by video conferencing. Chairperson Alisha Moopen, chairing in the absence of Chairman Dr. Azad Moopen, said the merger with Quality Care India Limited (QCIL, backed by Blackstone) is the largest M&A in the... NSE copy
30 Jul 2025Legal or regulatoryBoard of Aster DM Healthcare approved unaudited standalone and consolidated results for the quarter ended June 30, 2025, with an unmodified limited review report from Deloitte Haskins & Sells. The Board recommended a final dividend of INR 1 per equity share (face value INR 10) for FY 2024-25, subject to shareholder... NSE copy
30 Jul 2025Legal or regulatoryBoard of Aster DM Healthcare approved unaudited standalone and consolidated results for the quarter ended June 30, 2025, with an unmodified limited review opinion from Deloitte Haskins & Sells. The 17th AGM is set for September 4, 2025, with record date August 28, 2025 for e-voting and final dividend of INR 1 per... NSE copy

Filings with a management change, a legal or regulatory matter or a credit rating (by their tags), or naming an auditor, a resignation or a pledge of shares; newest first (27 in all). A list of what was filed, not a judgement of the company.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in